SERUM LIPID AND C-REACTIVE PROTEIN LEVELS BY TREATMENT RESPONSE FOLLOWING 8 WEEKS OF TOFACITINIB INDUCTION THERAPY IN PATIENTS WITH ULCERATIVE COLITIS

Christina Ha  1     Leonardo Salese  2     Chinyu Su  2     Krisztina B Gecse  3     John Woolcott  2     Rajiv Mundayat  4     David P. Hudesman  5     Jerome Paulissen     Walter Reinisch    
1 Inflammatory Bowel Disease Center, Cedars-Sinai Medical Center,Los Angeles,United States
2 Pfizer Inc,Collegeville,United States
3 Amsterdam UMC,Amsterdam,Netherlands
4 Pfizer Inc,New York,United States
5 Inflammatory Bowel Disease Center at NYU Langone Health,

Session
IBD (Posters)

Citation
United European Gastroenterology Journal 2020; 8 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing